Effect of IFN-γ on Innate Immune Cells

Clinical trial NCT02609932 · COMPLETED

Trial details

NCT number: NCT02609932
Sponsor: University of Colorado, Denver
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Granulomatous Disease

Start date: 2016-07-01
Primary completion: 2018-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.